Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maribavir vs valganciclovir in HSCT recipients with asymptomatic CMV infection
CTR20201035Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of maribavir in cytomegalovirus disease (CMV), sponsored by Takeda. Started Oct 2020; status: completed.
02
Drugs
maribavir
03
Conditions
cytomegalovirus disease (CMV)
Beyond the preview
Go deeper on CTR20201035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201035.